Skip to main content
Clinical Trials/NCT05044351
NCT05044351CompletedNot Applicable

Autofluorescence-guided Hemithyroidectomy in a Low-volume, Non-parathyroid Insitution: A Randomized Clinical Trial

Regional Hospital West Jutland2 sites in 1 country170 target enrollmentStarted: September 15, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
170
Locations
2
Primary Endpoint
Parathyroid gland identification rate

Study Overview

Brief Summary

Parathyroid damage and inadvertent excision unfortunately happens frequently in thyroid surgery. The use of near-infrared autofluorescence (NIRAF) intraoperatively, seems to be helpful in terms of parathyroid identification and preservation.

In order to cover every aspect of the impact of NIRAF in thyroid surgery, an evaluation in low-volume, non-parathyroid centers is needed:

Aim: To investigate the impact of NIRAF on hemithyroidectomy by evaluating parathyroid identification, damage and the rate of inadvertent parathyroid excision in a low-volume, non-parathyroid institution.

Detailed Description

Patients referred for hemithyroidectomy will be randomized to either:

(A) NIRAF-assisted hemithyroidectomy (Fluobeam LX) or (B) Conventional hemithyroidectomy. PTH and ionized calcium will assessed preoperatively, on postoperative day 1 (POD1) and one month following surgery. Parathyroid identification rates, rates of autoimplantation and inadvertently excised parathyroid glands will be assessed and compared.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Care Provider)

Masking Description

Patients and related health care staff will be blinded for the allocated intervention until the day of surgery

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients referred for thyroid lobectomy
  • Age > 18
  • Able to understand patient information
  • Able to give informed consent

Exclusion Criteria

  • Completion lobectomy
  • Need for accelerated surgery
  • Age < 18
  • Unable to understand patient information
  • Unable to give informed consent

Outcomes

Primary Outcomes

Parathyroid gland identification rate

Time Frame: Will be assessed at the time of surgery

Secondary Outcomes

  • Rate of autotransplantation(Will be assessed at the time of surgery)
  • Rate of inadvertent parathyroid excision(Will be assessed one month following surgery)

Investigators

Sponsor
Regional Hospital West Jutland
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ali Abood

MD

Regional Hospital West Jutland

Study Sites (2)

Loading locations...

Similar Trials